FDMT:4D Molecular Therapeutics Inc Snapshot | Charting | News | Options
$10.07 NASDAQ 3:14p ET
July 18 '26 		4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on FDMT
    No News Available
    4DMT Announces New Employment Inducement Grants
    4:04p ET July 17 '26 GlobeNewswire
    4DMT Announces Presentation at 44th Annual Scientific Meeting of the ...
    4:04p ET June 30 '26 GlobeNewswire
    4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial ...
    8:00a ET June 29 '26 GlobeNewswire
    4DMT Secures Strategic Credit Facility for up to $200 Million from He...
    8:00a ET June 29 '26 GlobeNewswire
    Vivani Medical Announces Appointment of August J. Moretti to Board of...
    7:30a ET June 26 '26 GlobeNewswire
    4DMT Announces New Employment Inducement Grants
    4:04p ET June 12 '26 GlobeNewswire
    4DMT to Participate in Upcoming Investor Conferences
    8:00a ET May 27 '26 GlobeNewswire
    4DMT Announces New Employment Inducement Grants
    4:06p ET May 15 '26 GlobeNewswire
    4DMT Reports First Quarter 2026 Financial Results, Operational Highli...
    4:04p ET May 7 '26 GlobeNewswire
    4DMT to Participate in Upcoming Investor Conferences
    8:00a ET May 4 '26 GlobeNewswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.